FDA limits Johnson and Johnson Vaccine due to blood clot risk

FDA, Released on 5/5/22

Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or

Continue...

FDA limits Johnson and Johnson Vaccine due to blood clot risk added by Herman James on 05/05/2022View all posts by Herman James ?+'